Reliable quantification of protein expression and cellular localization in histological sections

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Schlederer, Michaela ^a   Mueller, Kristina M ^a   Haybaeck, Johannes ^b   Heider, Susanne ^d   Huttary, Nicole ^d   Rosner, Margit ^d   Hengstschläger, Markus ^d   Moriggl, Richard ^a,c   Dolznig, Helmut ^d   Kenner, Lukas ^a,c,d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PROTEIN STAT5AB; TRANSCRIPTION FACTOR JUNB; UNCLASSIFIED DRUG; JUNB PROTEIN, MOUSE; STAT5 PROTEIN; STAT5A PROTEIN, MOUSE; STAT5B PROTEIN, MOUSE; TRANSCRIPTION FACTOR; TUMOR MARKER;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE DELETION; GENE PRODUCT; HAPLOINSUFFICIENCY; HEMIZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MEASUREMENT ACCURACY; MOUSE; NONHUMAN; OBSERVER VARIATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SCORING SYSTEM; T CELL LYMPHOMA; WESTERN BLOTTING; ANIMAL; CELL NUCLEUS; CYTOPLASM; GENETICS; KNOCKOUT MOUSE; METABOLISM; PROCEDURES;

ANIMALS; CELL NUCLEUS; CYTOPLASM; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; REPRODUCIBILITY OF RESULTS; STAT5 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84904270166     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100822     Document Type: Article

References (37)

1. Savage DG, Antman KH (2002) Imatinib mesylate-a new oral targeted therapy. N Engl J Med 346: 683-693. (Pubitemid 34815874)
2. Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, et al. (2007) ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest 117: 2051-2058. (Pubitemid 47224766)
3. Rudiger T, Hofler H, Kreipe HH, Nizze H, Pfeifer U, et al. (2002) Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists. Am J Surg Pathol 26: 873-882. (Pubitemid 34747639)
4. Walker RA (2006) Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment I. Histopathology 49: 406-410.
5. Taylor CR, Levenson RM (2006) Quantification of immunohistochemistry- issues concerning methods, utility and semiquantitative assessment II. Histopathology 49: 411-424. (Pubitemid 44401549)
6. Steiner GE, Ecker RC, Kramer G, Stockenhuber F, Marberger MJ (2000) Automated data acquisition by confocal laser scanning microscopy and image analysis of triple stained immunofluorescent leukocytes in tissue. J Immunol Methods 237: 39-50. (Pubitemid 30139501)
7. Paizs M, Engelhardt JI, Siklos L (2009) Quantitative assessment of relative changes of immunohistochemical staining by light microscopy in specified anatomical regions. J Microsc 234: 103-112.
8. Lehr HA, Jacobs TW, Yaziji H, Schnitt SJ, Gown AM (2001) Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis. Am J Clin Pathol 115: 814-822. (Pubitemid 32476706)
9. Cross SS (2001) Observer accuracy in estimating proportions in images: implications for the semiquantitative assessment of staining reactions and a proposal for a new system. J Clin Pathol 54: 385-390.
10. Umemura S, Itoh J, Itoh H, Serizawa A, Saito Y, et al. (2004) Immunohistochemical evaluation of hormone receptors in breast cancer: which scoring system is suitable for highly sensitive procedures? Appl Immunohistochem Mol Morphol 12: 8-13. (Pubitemid 38332312)
11. Diaz LK, Sneige N (2005) Estrogen receptor analysis for breast cancer: current issues and keys to increasing testing accuracy. Adv Anat Pathol 12: 10-19. (Pubitemid 40614485)
12. Perry GH, Dominy NJ, Claw KG, Lee AS, Fiegler H, et al. (2007) Diet and the evolution of human amylase gene copy number variation. Nat Genet 39: 1256-1260. (Pubitemid 47482688)
13. Gao H, Ouyang X, Banach-Petrosky W, Borowsky AD, Lin Y, et al. (2004) A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci U S A 101: 17204-17209. (Pubitemid 39627798)
14. Mueller KM, Kornfeld JW, Friedbichler K, Blaas L, Egger G, et al. (2011) Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice. Hepatology 54: 1398-1409.
15. Chiarle R, Gong JZ, Guasparri I, Pesci A, Cai J, et al. (2003) NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors. Blood 101: 1919-1927. (Pubitemid 36237594)
16. Kenner L, Hoebertz A, Beil T, Keon N, Karreth F, et al. (2004) Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J Cell Biol 164: 613-623. (Pubitemid 38233322)
17. Laimer D, Dolznig H, Kollmann K, Vesely PW, Schlederer M, et al. (2012) PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. Nat Med 18: 1699-1704.
18. Ecker RC, Rogojanu R, Streit M, Oesterreicher K, Steiner GE (2006) An improved method for discrimination of cell populations in tissue sections using microscopy-based multicolor tissue cytometry. Cytometry A 69: 119-123.
19. Ecker RC, Steiner GE (2004) Microscopy-based multicolor tissue cytometry at the single-cell level. Cytometry A 59: 182-190. (Pubitemid 38736293)
20. Steiner GE, Stix U, Handisurya A, Willheim M, Haitel A, et al. (2003) Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Lab Invest 83: 1131-1146. (Pubitemid 37013048)
21. Piechaczyk M, Farras R (2008) Regulation and function of JunB in cell proliferation. Biochem Soc Trans 36: 864-867.
22. Mueller KM, Themanns M, Friedbichler K, Kornfeld JW, Esterbauer H, et al. (2012) Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development. Mol Cell Endocrinol 361: 1-11.
23. Friedbichler K, Themanns M, Mueller KM, Schlederer M, Kornfeld JW, et al. (2012) Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer. Hepatology 55: 941-952.
24. Cui Y, Hosui A, Sun R, Shen K, Gavrilova O, et al. (2007) Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration. Hepatology 46: 504-513. (Pubitemid 47344786)
25. Abraham N, Ma MC, Snow JW, Miners MJ, Herndier BG, et al. (2005) Haploinsufficiency identifies STAT5 as a modifier of IL-7-induced lymphomas. Oncogene 24: 5252-5257. (Pubitemid 41192442)
26. Farras R, Baldin V, Gallach S, Acquaviva C, Bossis G, et al. (2008) JunB breakdown in mid-/late G2 is required for down-regulation of cyclin A2 levels and proper mitosis. Mol Cell Biol 28: 4173-4187. (Pubitemid 351813000)
27. Lee TK, Man K, Poon RT, Lo CM, Yuen AP, et al. (2006) Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition. Cancer Res 66: 9948-9956. (Pubitemid 44672047)
28. Cohen J (1968) Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 70: 213-220.
29. Taylor CR (1994) An exaltation of experts: concerted efforts in the standardization of immunohistochemistry. Hum Pathol 25: 2-11.
30. Sirota RL (2005) Error and error reduction in pathology. Arch Pathol Lab Med 129: 1228-1233.
31. Rhodes A, Jasani B, Balaton AJ, Miller KD (2000) Immunohistochemical demonstration of oestrogen and progesterone receptors: correlation of standards achieved on in house tumours with that achieved on external quality assessment material in over 150 laboratories from 26 countries. J Clin Pathol 53: 292-301. (Pubitemid 30180402)
32. Rexhepaj E, Brennan DJ, Holloway P, Kay EW, McCann AH, et al. (2008) Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer. Breast Cancer Res 10: R89.
33. Quon KC, Berns A (2001) Haplo-insufficiency? Let me count the ways. Genes Dev 15: 2917-2921. (Pubitemid 33078941)
34. Kemkemer R, Schrank S, Vogel W, Gruler H, Kaufmann D (2002) Increased noise as an effect of haploinsufficiency of the tumor-suppressor gene neurofibromatosis type 1 in vitro. Proc Natl Acad Sci U S A 99: 13783-13788. (Pubitemid 35215458)
35. Yu LR, Issaq HJ, Veenstra TD (2007) Phosphoproteomics for the discovery of kinases as cancer biomarkers and drug targets. Proteomics Clin Appl 1: 1042-1057.
36. Kelloff GJ, Sigman CC (2012) Cancer biomarkers: selecting the right drug for the right patient. Nat Rev Drug Discov 11: 201-214.
37. Hosui A, Kimura A, Yamaji D, Zhu BM, Na R, et al. (2009) Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-{beta} and STAT3 activation. J Exp Med 206: 819-831.